Yushin Company (6482) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
12 Nov, 2026Executive summary
H1 FY2027 net sales rose 9.9% YoY to ¥11,681m; operating profit increased to ¥961m from ¥147m on higher sales and improved gross profit margin.
Orders were steady, particularly in Japan and Asia; sales growth was led by custom-ordered equipment.
Financial highlights
Net sales ¥11,681m, up 9.9% YoY; gross profit ¥4,959m vs. ¥4,148m.
Operating profit ¥961m, up 552.7% YoY; ordinary profit ¥1,000m, up 512.3%; profit attributable to owners ¥723m, up 525.9%.
Comprehensive income was ¥740m vs. ¥443m YoY; prior-period results included ¥17.8m gain on subsidiary liquidation, while current-period extraordinary income included ¥4.2m gain on asset sales.
Total assets rose to ¥40,114m from ¥39,833m; net assets declined to ¥34,246m from ¥34,788m at FY2026 year-end.
Outlook and guidance
FY2027 forecast revised: net sales ¥26,000m (+12.5%), operating profit ¥2,200m (+166.1%), ordinary profit ¥2,200m (+142.2%), and parent-attributable profit ¥1,500m (+423.1%).
FY2027 forecast EPS is ¥47.31; forecasts reflect currently available information and actual results may differ materially.
FY2027 dividend forecast is ¥20 per share, comprising ¥10 interim and ¥10 year-end; projected dividends were revised.
Latest events from Yushin Company
- Strong sales and profit growth driven by custom equipment and robust overseas demand.6482
Q1 2027 - Sales surged 19.7% year-over-year, but profit margins narrowed on higher costs.6482
Q1 2025 - Sales and operating profit surged, but ordinary profit fell on forex losses; outlook steady.6482
Q2 2025 - Net sales rose 14.5% year-over-year, with robust growth in Japan and Europe.6482
Q3 2025 - Net sales and profit grew in FY2025, but FY2026 guidance signals declines amid global uncertainty.6482
Q4 2025 - Operating profit rose despite lower sales, with Asia growth offset by Europe weakness.6482
Q1 2026 - Profits fell sharply on weak medical equipment sales, but dividends and buybacks are maintained.6482
Q2 2026 - Profits and sales fell sharply year-over-year, with Europe showing the largest decline.6482
Q3 2026 - Profits and sales fell sharply in FY2026, but a strong rebound is forecast for FY2027.6482
Q4 2026